From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:2h1h.jpg|left|200px]] | + | {{Seed}} |
| | + | [[Image:2h1h.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_2h1h| PDB=2h1h | SCENE= }} | | {{STRUCTURE_2h1h| PDB=2h1h | SCENE= }} |
| | | | |
| - | '''E. coli heptosyltransferase WaaC with ADP-2-deoxy-2-fluoro heptose'''
| + | ===E. coli heptosyltransferase WaaC with ADP-2-deoxy-2-fluoro heptose=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | Lipopolysaccharides constitute the outer leaflet of the outer membrane of Gram-negative bacteria and are therefore essential for cell growth and viability. The heptosyltransferase WaaC is a glycosyltransferase (GT) involved in the synthesis of the inner core region of LPS. It catalyzes the addition of the first L-glycero-D-manno-heptose (heptose) molecule to one 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) residue of the Kdo2-lipid A molecule. Heptose is an essential component of the LPS core domain; its absence results in a truncated lipopolysaccharide associated with the deep-rough phenotype causing a greater susceptibility to antibiotic and an attenuated virulence for pathogenic Gram-negative bacteria. Thus, WaaC represents a promising target in antibacterial drug design. Here, we report the structure of WaaC from the Escherichia coli pathogenic strain RS218 alone at 1.9 A resolution, and in complex with either ADP or the non-cleavable analog ADP-2-deoxy-2-fluoro-heptose of the sugar donor at 2.4 A resolution. WaaC adopts the GT-B fold in two domains, characteristic of one glycosyltransferase structural superfamily. The comparison of the three different structures shows that WaaC does not undergo a domain rotation, characteristic of the GT-B family, upon substrate binding, but allows the substrate analog and the reaction product to adopt remarkably distinct conformations inside the active site. In addition, both binary complexes offer a close view of the donor subsite and, together with results from site-directed mutagenesis studies, provide evidence for a model of the catalytic mechanism.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_16963083}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 16963083 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_16963083}} |
| | | | |
| | ==About this Structure== | | ==About this Structure== |
| Line 33: |
Line 37: |
| | [[Category: Absence of c-terminal alpha-helix]] | | [[Category: Absence of c-terminal alpha-helix]] |
| | [[Category: Gt-b fold]] | | [[Category: Gt-b fold]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 05:45:32 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 07:08:02 2008'' |
Revision as of 04:08, 29 July 2008
Template:STRUCTURE 2h1h
E. coli heptosyltransferase WaaC with ADP-2-deoxy-2-fluoro heptose
Template:ABSTRACT PUBMED 16963083
About this Structure
2H1H is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.
Reference
Structure of the Escherichia coli heptosyltransferase WaaC: binary complexes with ADP and ADP-2-deoxy-2-fluoro heptose., Grizot S, Salem M, Vongsouthi V, Durand L, Moreau F, Dohi H, Vincent S, Escaich S, Ducruix A, J Mol Biol. 2006 Oct 20;363(2):383-94. Epub 2006 Jul 29. PMID:16963083
Page seeded by OCA on Tue Jul 29 07:08:02 2008
